NCT04344652 2025-09-26
Photoscreening for Retinoblastoma
Phoenix Children's Hospital
Phase NA Withdrawn
Clinical Trials
48 trialsNCT04214015 2025-06-05
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
Withdrawn
NCT06365970 2025-02-03
Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
University of Pittsburgh
Phase 2 Withdrawn
NCT05231733 2024-10-31
Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors
SparX Biotech(Jiangsu) Co., Ltd.
Phase 1 Withdrawn
NCT05515692 2024-07-23
Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT03905538 2024-03-01
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT05582031 2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2 Withdrawn
NCT05531708 2023-03-01
Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors
Shanghai Pudong Hospital
Phase 1 Withdrawn
NCT03789773 2023-02-01
Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy
University of Southern California
Phase NA Withdrawn
NCT04316169 2022-12-23
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Medical College of Wisconsin
Phase 1 Withdrawn
NCT05469490 2022-09-30
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT03427320 2022-07-11
Imaging of Advanced Tumours Using [131]I-IAZA
University of Alberta
Phase 1/2 Withdrawn
NCT05177276 2022-01-04
Selinexor Combination Ph 1 Study
Hackensack Meridian Health
Phase 1/2 Withdrawn
NCT04757090 2021-12-23
89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111
Washington University School of Medicine
Phase 2 Withdrawn
NCT04429204 2021-06-14
Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma
Jonsson Comprehensive Cancer Center
Phase NA Withdrawn
NCT03786419 2021-05-13
A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
Health Pharma Professional Research
Phase 2 Withdrawn
NCT03728205 2021-04-27
Yoga for Solid Tumor
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT04201145 2020-11-17
Pembrolizumab + Defactinib In Pleural Mesothelioma
Dana-Farber Cancer Institute
Phase 1 Withdrawn
NCT02691780 2019-12-30
Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors
Samsung Medical Center
Phase NA Withdrawn
NCT02747537 2019-09-09
Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan
Washington University School of Medicine
Phase 2 Withdrawn
NCT03166176 2019-05-20
TSC1/2_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT03166904 2019-05-20
RICTOR_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT02106559 2019-03-21
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT02845414 2018-10-03
Study of CD133KDEL Toxin in the Treatment for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT01325753 2018-07-03
Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT02661659 2018-05-14
A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy
University of Chicago
Phase 1 Withdrawn
NCT00980551 2017-03-03
RELRB1
Children's Hospital Medical Center, Cincinnati
Phase NA Withdrawn
NCT00607802 2017-01-19
Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT02639767 2016-12-07
Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Withdrawn
NCT02655432 2016-12-02
POPH
Université de Montréal
Withdrawn
NCT02656849 2016-07-01
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Dana-Farber Cancer Institute
Phase 2 Withdrawn
NCT02511600 2015-12-15
Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
M.D. Anderson Cancer Center
Phase 3 Withdrawn
NCT00003273 2015-12-03
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
NYU Langone Health
Phase 2 Withdrawn
NCT00733252 2015-10-02
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Case Comprehensive Cancer Center
Withdrawn
NCT02120118 2015-06-09
Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors
Shin Kong Wu Ho-Su Memorial Hospital
Phase 2 Withdrawn
NCT00769249 2015-03-19
Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers
Case Comprehensive Cancer Center
Withdrawn
NCT00668499 2014-05-21
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma
University of Southern California
Phase 1/2 Withdrawn
NCT01170871 2014-05-21
Ixabepilone and Pemetrexed/Solid Tumors
University of Southern California
Phase 1 Withdrawn
NCT00601614 2014-03-10
Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Mayo Clinic
Phase 1 Withdrawn
NCT00052403 2014-01-16
Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00009815 2013-12-19
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT00009828 2013-12-19
Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT01521299 2012-08-28
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors
Dartmouth-Hitchcock Medical Center
Phase 1 Withdrawn
NCT01151748 2012-05-14
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Stanford University
Phase 2 Withdrawn
NCT01353482 2012-03-22
MESO-02
University College, London
Phase 1/2 Withdrawn
NCT00159016 2011-04-28
Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.
Hadassah Medical Organization
Phase 2 Withdrawn
NCT00148993 2011-04-08
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
Hadassah Medical Organization
Phase 1/2 Withdrawn
NCT00149019 2011-04-08
Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.
Hadassah Medical Organization
Phase 2 Withdrawn